MAPK4 promotes prostate cancer by concerted activation of androgen receptor and AKT.
Shen T, Wang W, Zhou W, Coleman I, Cai Q, Dong B, Ittmann MM, Creighton CJ, Bian Y, Meng Y, Rowley DR, Nelson PS, Moore DD, Yang F.
Shen T, et al. Among authors: wang w.
J Clin Invest. 2021 Feb 15;131(4):e135465. doi: 10.1172/JCI135465.
J Clin Invest. 2021.
PMID: 33586682
Free PMC article.